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The relationship between inflammatory 
bowel disease and type 1 diabetes mellitus: 
a study of relative prevalence in comparison 
with population controls
To the Editor,
Genome wide association studies have identified that 
an overlap exists in the genetic architecture underpinning 
inflammatory bowel disease (IBD) and other immune-
mediated inflammatory diseases [1]. Epidemiological studies 
have established that IBD patients have a higher prevalence of 
asthma, psoriasis, rheumatoid arthritis and multiple sclerosis, 
than persons without IBD [2, 3]. However, data remains unclear 
regarding the association between IBD and type-1 diabetes 
mellitus (T1DM). We have examined the prevalence of IBD in 
T1DM and T1DM in IBD and assessed the effect of concurrent 
IBD in T1DM patients on glycaemic control and quality of life 
(QoL). 
Type 1 diabetes mellitus (n= 662) and IBD (n= 622) patients 
were recruited during attendance at outpatient clinics. Non-
diabetic controls (n= 602) were recruited from general practices 
within the South Yorkshire region. Demographic information was 
recorded from patient case notes, alongside stated diagnoses of 
T1DM and/or histology confirmed IBD. Diabetic controls were 
selected from the diabetes cohort matched for age and sex in a 2:1 
ratio for comparison of QoL and glycaemic control. Glycaemic 
control was assessed using HbA1c values and QoL using the Short 
Form-36 Version 2 (SF-36) questionnaire. 
We found that the prevalence of IBD was 12/662 (1.5%) in 
those with T1DM and 2/602 (0.3%) in controls (OR 5.5, 1.2-
24.9; p=0.03). The prevalence of T1DM in IBD patients was 
4/662 (0.6%), which is comparable with the UK adult population 
prevalence of T1DM (0.4% [4]; OR 1.5, 0.38-6.07; p=0.56). In 
T1DM-IBD patients, QoL scores were significantly lower in the 
general health and vitality domains compared to T1DM-only 
patients (p=0.004 and p=0.041, respectively; Fig. 1). Adverse QoL 
was not explained by changes in the glycaemic control (Fig. 2).  
In conclusion, the prevalence of IBD in T1DM was increased 
six-fold compared with that in the control population. However, 
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Fig. 1. Bar chart showing SF-36 scores for T1DM-IBD and T1DM-
only patients. (PF, physical functioning; RP, role-physical; BP, bodily 
pain; GH, general health; VT, vitality; SF, social functioning; RE, 
role-emotional; MH, mental health; PCS, physical component score 
[combines PF, RP, BP, GH]; MCS, mental component score [combines 
VT, SF, RE, MH]). QoL scores were significantly different for GH and 
VT domains (p=0.004 and 0.041, respectively).
Fig. 2. Box and whisker plot of HbA1c results for T1DM-IBD and 
T1DM-only. HbA1c was 7.7% in T1DM-IBD and 7.5% in T1DM-
only (p=0.43).
our data suggest that there is no increase in the prevalence of 
T1DM in IBD patients. Similar to our findings, a recent Swedish 
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study found an increase in the incidence of ulcerative colitis in the 
offspring of parents with T1DM [5]. Moreover, two large North 
American studies also reported no difference in the prevalence 
of T1DM in IBD patients compared with healthy controls [2, 
3]. Multiple shared susceptibility loci between IBD and T1DM 
have been described [6]. However, the clinical significance of 
these genes has yet to be established given the absence of a clear 
epidemiological link between these two diseases. Further studies 
are required to characterise the association between these two 
conditions.   
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Does anatomical distribution of colorectal 
polyps show a rightward shift? Analysis of 
2,372 colorectal polyps in 1,558 patients from 
Turkey
To the Editor,
We read the article of Visovan et al. [1] with great interest. 
In the last two decades, the literature has reported a change 
in the topographic distribution of colorectal cancer (CRC), 
comprising a shift towards the proximal colon [2, 3]. But as 
stated by the authors, data from the East are scarce. Since the 
majority of CRC arise from polyps, we aimed to evaluate the 
topographic distribution of colorectal polyps in our population 
over a six year period in order to assess any proximalization.
Colonoscopy procedures performed in Sisli Hamidiye 
Etfal Education and Research Hospital Gastroenterology 
Department between 2009 and 2014 were evaluated 
retrospectively. The gender, age and polyp localization in 
patients who were reported to have polyp(s) in colonoscopy 
were recorded from the hospital database.
A total of 1,558 patients who had 1,780 total colonoscopies 
accompanied with polypectomy(ies) were enrolled in the study. 
The mean age of the patients was 61.1±18.3 years, similar to 
the study mentioned above [1], as was the male predominance: 
933 (60%) males, and 625 (40%) females. Polyp locations 
were evaluated according to a total of 2,372 poylpectomies 
performed in 1,780 procedures. One thousand and sixty one 
(48.9%) of the polyps were located in the rectosigmoid region. 
The other sites of the polyps are shown in Table I. The frequency 
of the right-sided polyps (from cecum up to the splenic flexure) 
was 26.6 % in 2009, 25 % in 2010, 23.3 % in 2011, 27.9 % in 
2012, 26.2 % in 2013 and 28.5% in 2014.
We did not detect a shift in the localization of colorectal 
polyps from the left to the right side of the colon, at least 25% 
of the polyps were found in the right colon in our group. We 
could not confirm colonic polyp proximalization. However, 
we agree that rectosigmoidoscopy should not be considered 
sufficient and patients should be encouraged to undergo a 
total colonoscopy. 
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2009 124 143 184 95 40 35 9 5
2010 232 271 343 165 92 70 7 9
2011 198 225 297 145 83 53 11 5
2012 279 318 445 213 108 91 18 15
2013 444 490 637 318 152 102 39 26
2014 (8 months) 281 333 466 225 108 85 27 21
Total (n) 1558 1780 2372 1161 583 436 111 81
Total (%) 100 48.9 24.6 18.4 4.7 3.4
